Bacterial contamination of ophthalmic solutions used in an extended care facility

British Journal of Ophthalmology

Volumn 91, Issue 10, 2007, Pages 1308-1310

  Jokl, Danny H Kauffmann ^a,b,c   Wormser, Gary P ^a   Nichols, Neil S ^a   Montecalvo, Marisa A ^a   Karmen, Carol L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; EYE DROPS; MIOTIC AGENT; MYDRIATIC AGENT; STEROID;

ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; GLAUCOMA; HEALTH CARE FACILITY; HUMAN; LONG TERM CARE; NURSING HOME; PRIORITY JOURNAL; PROTEUS MIRABILIS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIA; DRUG CONTAMINATION; HOSPITAL UNITS; HUMANS; LONG-TERM CARE; OPHTHALMIC SOLUTIONS; PROTEUS MIRABILIS;

EID: 34848855795     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.115618     Document Type: Article

References (20)

1. Montecalvo MA, Karmen CL, Alampur SK, et al. Contaminated solutions with endophthalmitis. Infect Dis Clin Prac 1993;2:199- 202.
2. Donzis PB, Mondino BJ, Weissman BA, et al. Microbial contamination of contact lens care systems. Amer J Opthalmol 1987;104:325-33.
3. Wilson LA, Schlitzer RL, Ahearn DG. Pseudomonas corneal ulcers associated with soft contact lens wear. Amer J Opthalmol 1981;92:546-54.
4. Parment P, Ronnerstam R. Soft contact lens keratitis associated with Serratia marcesens. Acta Ophtalmol 1981;59:560-65.
5. Patrinely JR, Wilhelmus KR, Rubin JM, et al. Bacterial keratitis associated with extended wear soft contact lenses. CLAO 1985;11:234-36.
6. Mayo MS, Schlitzer RL, Ward MA, et al. Assocation of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Micro 1987;25:1398-400.
7. MMWR Morb Mortal Weekly Rep 2006;55:563-4.
8. Hovding G, Sjursen M. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles. Acta Ophthalmol 1982;60:213-22.
9. Stevens JD, Matheson MM. Survey of the contamination of eye drops of hospital inpatients and recommendations for the changing of current practice in eye drop dispensing. Br J Ophthalmol 1992;37:69-70.
10. Marion AD, Tpert MJ. Bacterial contamination of timolol in use by a non-selected clinic population. Invest Ophthalmol Vis Sci, 1986;36, (Suppl).
11. Geyer O, Bottone EJ, Podos JM, et al. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 1995;76:376-79.
12. Schein OD, Hibberd PL, Starck T, et al. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992;110:82-5.
13. Clark PJ, Ong B, Stanley CB. Contamination of diagnostic ophthalmic solutuions in primary care settings. Mil Med 1997;162:501-6.
14. Kowalski RP, Romosiowski EG, Waikhon B, et al. The survival of adenovirus in multidose bottles of topical fluorescein. Am J Ophthalmol 1998;126:835-6.
15. Barkamn R, Germanis M, Karpe G, et al. Preservatives in eye drops. Acta Ophthalmol 1969;47:461-75.
16. Joklik WF, Willett HP, Amos DB, Wilfest CM, eds. Zissner microbiology. 20th edn. Appleton Lange, 1992:551-2.
17. Aslund B, Olson OT, Sondell E. Studies of in-use microbial contamination of eye drops. Acta Pharm Suec 1978;15:389-94.
18. Coad CT, Osto MS, Wilhelmus KR. Bacterial contamination of eye drop dispenser. Am J Ophthalmol 1984;98:548-51.
19. Schein OD, Wason PJ, Boruchoff SA, et al. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol 1988;105:361-5.
20. Mason BL, Alfonso EC, Miller D. In-use study of potential bacterial contamination of ophthalmic moxifloxacin. J Cataract Refract Surg 2005;31:1773-6.